Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer
- 142 Downloads
Non-coding RNAs (ncRNAs) have been a hot topic for many years in the field of cancer research, especially miRNAs and lncRNAs. Because they play critical roles in regulating various cellular processes and are more often involved in tumorigenesis than protein-coding genes. But the cross talk between miRNAs and lncRNAs in cancer has been scarcely studied. This article aims to provide a retrospective review of the latest research on the link between miRNAs and lncRNAs in lung cancer and discusses their potential role as diagnostic biomarkers and therapeutic targets for lung cancer in clinical practice.
We reviewed literatures about ncRNAs and lung cancer from PUBMED databases in this article.
As shown in our review, miRNAs and lncRNAs could represent underlying targets for diagnosis, therapy, prognosis, and drug resistence of lung cancer. By acting as ceRNAs, lncRNAs can competitively inhibit the expression levels of miRNAs, and the lncRNA/miRNA axis can contribute to tumorigenesis, metastasis, and mutidrug resistance in lung cancer via various classic signaling pathways or related proteins.
Based on present knowledge, ncRNAs may provide a novel perspective to understand the pathogenesis of lung cancer and could be candidates in screening of therapeutic targets for lung cancer.
KeywordsmicroRNAs Long non-coding RNAs Lung cancer Tumorigenesis EMT
All data generated or analyzed during this study are included in this published article.
JZ and PG contributed to the conception of the study. JL, LZ, WH, and RW contributed significantly to the analysis and manuscript preparation; TG performed the data analyses and wrote the manuscript. All authors read and approved the final manuscript.
This work is partly supported by the National Natural Science Foundation of China (Grant no. 81672297).
Compliance with ethical standards
Conflict of interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
This article does not contain any studies with animals or human participants performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- Alexius-Lindgren M, Andersson E, Lindstedt I, Engstrom W (2014) The RECK gene and biological malignancy—its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res 34:3867–3873Google Scholar
- Ambros V (2003) MicroRNA pathways in flies and worms: growth, death, fat, stress and timing. Cell 113:673–676Google Scholar
- Bagheri A et al (2017) Altered miR-223 expression in sputum for diagnosis of non-small cell lung cancer. Avicenna J Med Biotechnol 9:189–195Google Scholar
- Basumallik N, Agarwal M (2018) Cancer, lung, small cell (oat cell). StatPearls, Treasure IslandGoogle Scholar
- Brannan CI, Dees EC, Ingram RS, Tilghman SM (1990) The product of the H19 gene may function as an RNA. Mol Cell Biol 10:28–36Google Scholar
- Brockdorff N et al (1992) The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71:515–526Google Scholar
- Brown CJ, Hendrich BD, Rupert JL, Lafreniere RG, Xing Y, Lawrence J, Willard HF (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527–542Google Scholar
- Coccia EM, Cicala C, Charlesworth A, Ciccarelli C, Rossi GB, Philipson L, Sorrentino V (1992) Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol 12:3514–3521Google Scholar
- Iguchi T et al (2015) A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res 35:1385–1388Google Scholar
- Kondo M, Takahashi T (1996) Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer. Nihon Rinsho Jpn J Clin Med 54:492–496Google Scholar
- Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T (1995) Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10:1193–1198Google Scholar
- Kruer TL, Dougherty SM, Reynolds L, Long E, de Silva T, Lockwood WW, Clem BF (2016) Expression of the lncRNA maternally expressed gene 3 (MEG3) contributes to the control of lung cancer cell proliferation by the Rb pathway. PLoS One 11:e0166363. https://doi.org/10.1371/journal.pone.0166363 Google Scholar
- Li J et al (2016) LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204. Am J Cancer Res 6:1099–1107Google Scholar
- McDougall JK, Dunn AR, Jones KW (1972) In situ hybridization of adenovirus RNA and DNA. Nature 236:346–348Google Scholar
- Nana-Sinkam SP, Geraci MW (2006) MicroRNA in lung cancer. J Thorac Oncol 1:929–931Google Scholar
- Su X, Xing J, Wang Z, Chen L, Cui M, Jiang B (2013) microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin J Cancer Res 25:235–239. https://doi.org/10.3978/j.issn.1000-9604.2013.03.08 Google Scholar
- Sun SJ, Lin Q, Ma JX, Shi WW, Yang B, Li F (2017) Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci 21:504–510Google Scholar
- Watanabe Y, Yamamoto M (1994) S. pombe mei2+ encodes an RNA-binding protein essential for premeiotic DNA synthesis and meiosis I, which cooperates with a novel RNA species meiRNA. Cell 78:487–498Google Scholar
- Wendler A, Keller D, Albrecht C, Peluso JJ, Wehling M (2011) Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells. Oncol Rep 25:273–279Google Scholar
- Zhang Q, Geng PL, Yin P, Wang XL, Jia JP, Yao J (2013) Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev 14:2311–2315Google Scholar
- Zhang J, Zhang B, Wang T, Wang H (2015) LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis. Int J Clin Exp Med 8:5499–5505Google Scholar
- Zhang N, Yang GQ, Shao XM, Wei L (2016b) GAS5 modulated autophagy is a mechanism modulating cisplatin sensitivity in NSCLC cells. Eur Rev Med Pharmacol Sci 20:2271–2277Google Scholar